Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors

Kuan HU; Wenyu WU; Lin XIE; Hao GENG; Yiding ZHANG; Masayuki HANYU; Lulu ZHANG; Yinghuan LIU; Kotaro NAGATSU; Hisashi SUZUKI; Jialin GUO; Yundong WU; Zigang LI; Feng WANG; Mingrong ZHANG.
Acta Pharmaceutica Sinica B ; (6): 1363-1376, 2022.
Artículo en Inglés | WPRIM | ID: wpr-929343

Documentos relacionados

  1. Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors.
  2. Exploring Geometrical, Electronic and Spectroscopic Properties of 2-Nitroimidazole-Based Radiopharmaceuticals via Computational Chemistry Methods.
  3. Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression.